Response Genetics (RGDX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-4.02M
Depreciation and amortization	192.17K
Share-based compensation	107.25K
Bad debt expense	1.9M
Loss on sale of property and equipment
Accounts receivable	-150.84K
Prepaid expenses and other current assets	230.69K
Accounts payable	97.59K
Accrued expenses	-245.96K
Accrued royalties	-4.11K
Accrued payroll and related liabilities	-22.32K
Deferred revenue
Net cash used in operating activities	-1.88M
Purchase of property and equipment
Net cash used in investing activities	-2.41K
Net proceeds from issuance of common stock
Capital contributions
Net cash provided by financing activities	1.42M
Effect of foreign exchange rates on cash and cash equivalents	-27.91K
Net decrease in cash and cash equivalents	-487.83K
Beginning of period	2.22M
End of period	1.73M
Income taxes
Interest	377.48K

Entities mentioned with RGDX

View All Entities